NUCLEAR RECEPTOR BINDING SET DOMAIN PROTEINS: ORCHESTRATING ANTI-TUMOR IMMUNITY AND THE PROMISE OF TARGETED DEGRADATION THERAPIES. (2024). European Journal of Emerging Molecular Sciences, 1(01), 69-79. https://parthenonfrontiers.com/index.php/ejems/article/view/31